BCAT1 and pancreatic ductal adenocarcinoma: Likewise, suppression of BCAT1 in pancreatic ductal adenocarcinoma (PDAC) did not lead to a reduction in tumor growth, and patients with PDAC expressed low levels of tumor BCAT1 and displayed increased plasma BCAAs levels [12▪].